IPQ Inside the global regulatory dialogue

Post-Approval Change Regulatory Burden Draws Heat at Japan Biotech CMC Strategy Forum

Feb 6th, 2014

Please Log in to print the full article

Industry associations have been meeting with Japanese regulators to highlight the problems they are experiencing in Japan’s process for regulating post-approval manufacturing changes, including a lack of flexibility around biotech product changes that results in...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications